-
21
EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells
Published 2025-01-01Subjects: Get full text
Article -
22
Emerging targeted therapies in oral oncology: Focus on EGFR inhibition
Published 2024-09-01Subjects: “…Epidermal growth factor receptor (EGFR)…”
Get full text
Article -
23
The potential mechanism of Isodon suzhouensis against COVID-19 via EGFR/TLR4 pathways
Published 2024-11-01Subjects: Get full text
Article -
24
Mogroside ⅡE, an in vivo metabolite of sweet agent, alleviates acute lung injury via Pla2g2a-EGFR inhibition
Published 2024-01-01Subjects: Get full text
Article -
25
Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Published 2025-02-01Subjects: “…HER2 (human epidermal growth factor receptor 2) status…”
Get full text
Article -
26
Quercetin inhibits truncated isoform of dopamine- and cAMP-regulated phosphoprotein as adjuvant treatment for trastuzumab therapy resistance in HER2-positive breast cancer
Published 2024-09-01Subjects: “…p95-human epidermal growth factor receptor 2 (her2)…”
Get full text
Article -
27
Characterisation of IGF-1 (rs7136446) and IL-6 (rs1800795) polymorphisms among breast cancer patients in western Algeria
Published 2024-10-01Subjects: Get full text
Article -
28
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Published 2025-01-01Subjects: “…hormone receptors human epidermal growth factor receptor 2 (HER2)…”
Get full text
Article